A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects (Q33628316)

28 July 2017

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects (English)

1 reference

28 July 2017

0 references

1 reference

Milligan NM

1

1 reference

28 July 2017

Newcombe R

series ordinal

2

1 reference

28 July 2017

Compston DA

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1987

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

28 July 2017

1 reference

28 July 2017

50

1 reference

28 July 2017

511-516

1 reference

28 July 2017

5

1 reference

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

Methylprednisolone therapy in multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

High dose intravenous methyl prednisolone in acute exacerbations of multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

The long-term treatment of multiple sclerosis with corticoids

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

High-dose intravenous methylprednisolone in myasthenia gravis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

Intravenous methylprednisolone for multiple sclerosis in relapse

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

Diagnosis and classification of multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

A clinical and laboratory study of benign multiple sclerosis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1031960

Long-term treatment of multiple sclerosis with corticotrophin

30 October 2018

1 reference

12 December 2020

“Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis

1 reference

12 December 2020

Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis

1 reference

12 December 2020

Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy

1 reference

12 December 2020

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study

1 reference

12 December 2020

USE OF AN ORAL CORTICOSTEROID IN THE TREATMENT OF MULTIPLE SCLEROSIS; A DOUBLE-BLIND STUDY

1 reference

12 December 2020

Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.)

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.50.5.511

1 reference

28 July 2017

1 reference

28 July 2017

1 reference